scholarly journals A novel DNA damage recognition protein in Schizosaccharomyces pombe

2006 ◽  
Vol 34 (8) ◽  
pp. 2347-2354 ◽  
Author(s):  
S. J. Pearson
Biochemistry ◽  
1990 ◽  
Vol 29 (24) ◽  
pp. 5872-5880 ◽  
Author(s):  
Brian A. Donahue ◽  
Marianne Augot ◽  
Steven F. Bellon ◽  
Daniel K. Treiber ◽  
Jeffrey H. Toney ◽  
...  

1992 ◽  
Vol 282 (1) ◽  
pp. 203-207 ◽  
Author(s):  
C C K Chao

We have previously identified damage-recognition proteins that bind to cisplatin[cis-diamminedichloroplatinum(II), a DNA cross-linking agent]- or u.v.-modified DNA in HeLa cells [Chao, Huang, Huang & Lin-Chao (1991) Mol. Cell. Biol. 11, 2075-2080; Chao, Huang, Lee & Lin-Chao (1991) Biochem. J. 277, 875-878]. In the present study we compared damage-recognition proteins in cells expressing different sensitivities to DNA damage. An increase in damage-recognition proteins and an enhancement of plasmid re-activation were detected in HeLa cells resistant to cisplatin and u.v. However, repair-defective cells derived from xeroderma-pigmentosum (a rare skin disease) patients did not express less cisplatin damage-recognition proteins than repair-competent cells, suggesting that damage-recognition-protein expression may not be related to DNA repair. By contrast, cells resistant to DNA damage consistently expressed high levels of u.v.-modified-DNA damage-recognition proteins. The results support the notion that u.v. damage-recognition proteins are different from those that bind to cisplatin. These findings also suggest that the damage-recognition proteins identified could be used as potential indicators of the sensitivity or resistance of cells to u.v.


2021 ◽  
Author(s):  
Kerry Silva McPherson ◽  
Dmitry Korzhnev

Cellular DNA damage response (DDR) is an extensive signaling network that orchestrates DNA damage recognition, repair and avoidance, cell cycle progression and cell death. DDR alternation is a hallmark of...


Blood ◽  
2017 ◽  
Vol 130 (24) ◽  
pp. 2631-2641 ◽  
Author(s):  
Brenton G. Mar ◽  
S. Haihua Chu ◽  
Josephine D. Kahn ◽  
Andrei V. Krivtsov ◽  
Richard Koche ◽  
...  

Key Points Alterations of SETD2, a histone 3 lysine 36 trimethyl (H3K36me3) transferase leads to resistance to DNA damaging-chemotherapy in leukemia. Low H3K36me3 levels impair DNA damage response and increase mutation rate, which may be targeted by H3K36me3 demethylase inhibition.


2005 ◽  
Vol 125 (1-2) ◽  
pp. 119-126 ◽  
Author(s):  
Piotr Widlak ◽  
Monika Pietrowska ◽  
Joanna Lanuszewska

Sign in / Sign up

Export Citation Format

Share Document